Table 1.

Clinical definition for primary resistance to immunotherapy–targeted therapy combinations

Resistance phenotype	Drug exposure requirement	Best response
Primary resistance	8–12 weeks* (2 cycles)	PD SD <6 months

*In the absence of toxicity or progression while on treatment.

PD, progressive disease; SD, stable disease.